The answer is in your ? stagman. Why would a director buy at 2.3c 160K and then dilute the stock. This will be heading north.Short term pain for long term gain/risk. I think there is more to this story that will unfold.
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game